Zevra Therapeutics (ZVRA) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts11

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$12.01

Median Target+114.24%

$25.73

Potential upside vs current price

Current Stock Price

$12.01

Median Target+114.24%

$25.73

Potential upside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts11

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$12.01

Median Target+114.24%

$25.73

Potential upside vs current price

Current Stock Price

$12.01

Median Target+114.24%

$25.73

Potential upside vs current price

Zevra Therapeutics, Inc.